Capital World Investors Dexcom Inc Transaction History

Capital World Investors

$625 Billion
Q3 2024

A detailed history of Capital World Investors transactions in Dexcom Inc stock. As of the latest transaction made, Capital World Investors holds 7,627,636 shares of DXCM stock, worth $612 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares

7,627,636

Previous 8,310,007 8.21%

Holding current value

$612 Million

Previous $942 Million 45.74%

% of portfolio

0.08%

Previous 0.16%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$64.0 - $116.06 $43.7 Million - $79.2 Million	-682,371 Reduced 8.21%	7,627,636 $511 Million
Q2 2024 Aug 13, 2024	BUY	$110.31 - $140.45 $26.2 Million - $33.4 Million	237,877 Added 2.95%	8,310,007 $942 Million
Q1 2024 May 14, 2024	SELL	$114.22 - $140.1 $138 Million - $169 Million	-1,206,555 Reduced 13.0%	8,072,130 $1.12 Billion
Q4 2023 Feb 13, 2024	BUY	$75.49 - $124.16 $397 Million - $653 Million	5,256,092 Added 130.66%	9,278,685 $1.15 Billion
Q3 2023 Nov 13, 2023	BUY	$86.06 - $137.93 $13.1 Million - $21 Million	152,026 Added 3.93%	4,022,593 $375 Million
Q2 2023 Aug 11, 2023	BUY	$112.47 - $130.98 $14 Million - $16.3 Million	124,197 Added 3.32%	3,870,567 $497 Million
Q1 2023 May 15, 2023	SELL	$104.0 - $122.92 $9.26 Million - $10.9 Million	-89,032 Reduced 2.32%	3,746,370 $435 Million
Q4 2022 Feb 14, 2023	BUY	$84.98 - $122.67 $5.88 Million - $8.49 Million	69,173 Added 1.84%	3,835,402 $434 Million
Q3 2022 Nov 14, 2022	BUY	$76.35 - $94.18 $3.61 Million - $4.46 Million	47,344 Added 1.27%	3,766,229 $303 Million
Q2 2022 Aug 15, 2022	BUY	$67.99 - $132.89 $191 Million - $374 Million	2,812,950 Added 310.5%	3,718,885 $277 Million
Q1 2022 May 16, 2022	SELL	$94.08 - $130.2 $45.3 Million - $62.6 Million	-481,008 Reduced 34.68%	905,935 $463 Million
Q4 2021 Feb 14, 2022	SELL	$129.87 - $162.82 $15.6 Million - $19.5 Million	-119,866 Reduced 7.95%	1,386,943 $745 Million
Q3 2021 Nov 15, 2021	SELL	$106.71 - $143.18 $21,128 - $28,349	-198 Reduced 0.01%	1,506,809 $824 Million
Q2 2021 Aug 16, 2021	BUY	$80.99 - $107.93 $15.7 Million - $20.9 Million	193,951 Added 14.77%	1,507,007 $643 Million
Q1 2021 May 14, 2021	BUY	$84.79 - $104.74 $169 - $209	2 Added 0.0%	1,313,056 $472 Million
Q4 2020 Feb 12, 2021	SELL	$78.0 - $104.5 $34.7 Million - $46.5 Million	-445,112 Reduced 25.32%	1,313,054 $485 Million
Q3 2020 Nov 13, 2020	SELL	$95.51 - $112.95 $2.25 Million - $2.67 Million	-23,609 Reduced 1.33%	1,758,166 $725 Million
Q2 2020 Aug 14, 2020	BUY	$62.68 - $105.34 $14.5 Million - $24.4 Million	231,712 Added 14.95%	1,781,775 $722 Million
Q1 2020 May 15, 2020	SELL	$47.79 - $75.63 $79.1 Million - $125 Million	-1,654,534 Reduced 51.63%	1,550,063 $417 Million
Q4 2019 Feb 18, 2020	SELL	$36.62 - $57.29 $32.9 Million - $51.4 Million	-897,304 Reduced 21.88%	3,204,597 $701 Million
Q3 2019 Nov 14, 2019	SELL	$35.53 - $43.8 $769,757 - $948,926	-21,665 Reduced 0.53%	4,101,901 $612 Million
Q2 2019 Aug 14, 2019	BUY	$27.84 - $38.92 $26 Million - $36.3 Million	932,566 Added 29.22%	4,123,566 $618 Million
Q1 2019 May 15, 2019	BUY	$28.07 - $38.18 $58.2 Million - $79.2 Million	2,074,000 Added 185.68%	3,191,000 $380 Million
Q4 2018 Feb 14, 2019	BUY	$26.99 - $37.37 $4.32 Million - $5.98 Million	160,000 Added 16.72%	1,117,000 $134 Million
Q3 2018 Nov 14, 2018	SELL	$23.35 - $36.72 $98.5 Million - $155 Million	-4,218,000 Reduced 81.51%	957,000 $137 Million
Q2 2018 Aug 14, 2018	SELL	$17.54 - $25.22 $1.54 Million - $2.22 Million	-88,000 Reduced 1.67%	5,175,000 $492 Million
Q1 2018 May 15, 2018	BUY	$13.06 - $18.54 $24.3 Million - $34.5 Million	1,860,000 Added 54.66%	5,263,000 $390 Million
Q4 2017 Feb 14, 2018	BUY	$11.12 - $15.38 $37.8 Million - $52.3 Million	3,403,000	3,403,000 $195 Million

Others Institutions Holding DXCM

# of Institutions

1,014

Shares Held

351M

Call Options Held

5.51M

Put Options Held

5.6M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital World Investors, based on Form 13F filings with the SEC.

News

Stay updated on Capital World Investors with notifications on news.

Account

Capital World Investors Dexcom Inc Transaction History